These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 38965630)

  • 41. Novel 2-(5-Aryl-4,5-Dihydropyrazol-1-yl)thiazol-4-One as EGFR Inhibitors: Synthesis, Biological Assessment and Molecular Docking Insights.
    Al-Warhi T; El Kerdawy AM; Said MA; Albohy A; Elsayed ZM; Aljaeed N; Elkaeed EB; Eldehna WM; Abdel-Aziz HA; Abdelmoaz MA
    Drug Des Devel Ther; 2022; 16():1457-1471. PubMed ID: 35607598
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Design, synthesis and biological evaluation of 2,3-dihydro-[1,4]dioxino[2,3-f]quinazoline derivatives as EGFR inhibitors.
    Qin X; Yang L; Liu P; Yang L; Chen L; Hu L; Jiang M
    Bioorg Chem; 2021 May; 110():104743. PubMed ID: 33714020
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Novel quinazolin-2-yl 1,2,3-triazole hybrids as promising multi-target anticancer agents: Design, synthesis, and molecular docking study.
    El Hamaky NFM; Hamdi A; Bayoumi WA; Elgazar AA; Nasr MNA
    Bioorg Chem; 2024 Jul; 148():107437. PubMed ID: 38749114
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Design, synthesis, molecular docking, and anticancer evaluations of 1-benzylquinazoline-2,4(1H,3H)-dione bearing different moieties as VEGFR-2 inhibitors.
    El-Adl K; El-Helby AA; Sakr H; El-Hddad SSA
    Arch Pharm (Weinheim); 2020 Aug; 353(8):e2000068. PubMed ID: 32510731
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Novel benzothiazole-based dual VEGFR-2/EGFR inhibitors targeting breast and liver cancers: Synthesis, cytotoxic activity, QSAR and molecular docking studies.
    Abd El-Meguid EA; Naglah AM; Moustafa GO; Awad HM; El Kerdawy AM
    Bioorg Med Chem Lett; 2022 Feb; 58():128529. PubMed ID: 35007724
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Synthesis, cytotoxic evaluation, and molecular docking studies of novel quinazoline derivatives with benzenesulfonamide and anilide tails: Dual inhibitors of EGFR/HER2.
    Alkahtani HM; Abdalla AN; Obaidullah AJ; Alanazi MM; Almehizia AA; Alanazi MG; Ahmed AY; Alwassil OI; Darwish HW; Abdel-Aziz AA; El-Azab AS
    Bioorg Chem; 2020 Jan; 95():103461. PubMed ID: 31838290
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Synthesis, Cytotoxicity and Molecular Docking Studies of the 9-Substituted 5-Styryltetrazolo[1,5-c]quinazoline Derivatives.
    Mphahlele MJ; Gildenhuys S; Parbhoo N
    Molecules; 2017 Oct; 22(11):. PubMed ID: 29072619
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Synthesis, biological evaluation and molecular docking studies of novel thiopyrimidine analogue as apoptotic agent with potential anticancer activity.
    Haffez H; Taha H; Rabie MA; Awad SM; Zohny YM
    Bioorg Chem; 2020 Nov; 104():104249. PubMed ID: 32911199
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Design, synthesis, and anti-cancer evaluation of new pyrido[2,3-d]pyrimidin-4(3H)-one derivatives as potential EGFRWT and EGFRT790M inhibitors and apoptosis inducers.
    Elzahabi HSA; Nossier ES; Alasfoury RA; El-Manawaty M; Sayed SM; Elkaeed EB; Metwaly AM; Hagras M; Eissa IH
    J Enzyme Inhib Med Chem; 2022 Dec; 37(1):1053-1076. PubMed ID: 35821615
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Benzoxazole derivatives as new generation of anti-breast cancer agents.
    Omar AME; AboulWafa OM; El-Shoukrofy MS; Amr ME
    Bioorg Chem; 2020 Mar; 96():103593. PubMed ID: 32004897
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Design, Synthesis, Molecular Docking, and Biological Evaluation of Isatin-Based Fused Heterocycles As Epidermal Growth Factor Receptor Inhibitors.
    Kumar A; Kumar B; Bhatia R
    Assay Drug Dev Technol; 2023 Jul; 21(5):222-233. PubMed ID: 37439798
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Discovery of new quinazolin-4(3H)-ones as VEGFR-2 inhibitors: Design, synthesis, and anti-proliferative evaluation.
    Eissa IH; El-Helby AA; Mahdy HA; Khalifa MM; Elnagar HA; Mehany ABM; Metwaly AM; Elhendawy MA; Radwan MM; ElSohly MA; El-Adl K
    Bioorg Chem; 2020 Dec; 105():104380. PubMed ID: 33128967
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Synthesis, molecular modeling and anti-cancer evaluation of a series of quinazoline derivatives.
    Khodair AI; Alsafi MA; Nafie MS
    Carbohydr Res; 2019 Dec; 486():107832. PubMed ID: 31622868
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Design, synthesis, biological assessment and molecular docking studies of new 2-aminoimidazole-quinoxaline hybrids as potential anticancer agents.
    Ghanbarimasir Z; Bekhradnia A; Morteza-Semnani K; Rafiei A; Razzaghi-Asl N; Kardan M
    Spectrochim Acta A Mol Biomol Spectrosc; 2018 Apr; 194():21-35. PubMed ID: 29310028
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Design and biological evaluation of 3-substituted quinazoline-2,4(1
    Hassan A; Mubarak FAF; Shehadi IA; Mosallam AM; Temairk H; Badr M; Abdelmonsef AH
    J Enzyme Inhib Med Chem; 2023 Dec; 38(1):2189578. PubMed ID: 36919632
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Quinazoline analogues as cytotoxic agents; QSAR, docking, and
    Emami L; Sabet R; Khabnadideh S; Faghih Z; Thayori P
    Res Pharm Sci; 2021 Oct; 16(5):528-546. PubMed ID: 34522200
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Synthesis and biological effect of halogen substituted phenyl acetic acid derivatives of progesterone as potent progesterone receptor antagonists.
    Cabeza M; Bratoeff E; Gómez G; Heuze I; Rojas A; Ochoa M; Palomino MA; Revilla C
    J Steroid Biochem Mol Biol; 2008 Sep; 111(3-5):232-9. PubMed ID: 18625316
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Synthesis, anticancer effect and molecular modeling of new thiazolylpyrazolyl coumarin derivatives targeting VEGFR-2 kinase and inducing cell cycle arrest and apoptosis.
    Mohamed TK; Batran RZ; Elseginy SA; Ali MM; Mahmoud AE
    Bioorg Chem; 2019 Apr; 85():253-273. PubMed ID: 30641320
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Design, synthesis and molecular modeling of new 4-phenylcoumarin derivatives as tubulin polymerization inhibitors targeting MCF-7 breast cancer cells.
    Batran RZ; Kassem AF; Abbas EMH; Elseginy SA; Mounier MM
    Bioorg Med Chem; 2018 Jul; 26(12):3474-3490. PubMed ID: 29793751
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Synthesis and Preclinical Evaluation of Indole Triazole Conjugates as Microtubule Targeting Agents that are Effective against MCF-7 Breast Cancer Cell Lines.
    Yele V; Pindiprolu SKSS; Sana S; Ramamurty DSVNM; Madasi JRK; Vadlamani S
    Anticancer Agents Med Chem; 2021; 21(8):1047-1055. PubMed ID: 32981511
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.